Mental Process
No Recent News on BetterHelp’s Quiet AI Expansion; Focus Remains on Insurance Growth
Teladoc; BetterHelp; insurance expansion; UpLift acquisition; mental health; revenue decline
VC Funding Uptick in Back Half of 2025 Has Analysts Hopeful for 2026
venture capital; VC funding; 2025 H2; 2026 outlook; biotech; MassBio; IPO window; M&A activity; interest rates; AI-driven investment
VC Funding Uptick in Back Half of 2025 Has Analysts Hopeful for 2026
venture capital; VC funding; 2025 H2; 2026 outlook; biotech; MassBio; IPO window; M&A activity; interest rates; AI-driven investment
VC Funding Uptick in Back Half of 2025 Has Analysts Hopeful for 2026
venture capital; VC funding; 2025 H2; 2026 outlook; biotech; MassBio; IPO window; M&A activity; interest rates; AI-driven investment
VC Funding Uptick in Back Half of 2025 Has Analysts Hopeful for 2026
venture capital; VC funding; 2025 H2; 2026 outlook; biotech; MassBio; IPO window; M&A activity; interest rates; AI-driven investment
Variant Bio Launches Inference, the World’s First Agentic AI Genomic Drug Discovery Platform
Variant Bio; Inference; agentic AI; genomic drug discovery; AI platform
FDA Policy Tracker: 2025 Was a Year of Change
FDA; 2025; Trump Administration; Food Safety; FSMA 204; GRAS Reform; Drug Approvals; Recall Improvements
No public results for “Take the Biopharma Sentiment Index” Q1 2026 yet
Biopharma Sentiment Index; Q1 2026; biopharma executives; life sciences sentiment; 2026 outlook; M&A activity; AI in biopharma; geopolitical risk; survey data
The Endpoints 100: Biotech CEOs are feeling more upbeat about the road ahead
Endpoints 100; E100 survey; biotech CEOs; biopharma executives; industry sentiment; market recovery; dealmaking; IPO window; Trump administration; FDA reorganization; tariffs; 2025 outlook
Recent news on Biopharma Sentiment Index (BPSI)
Biopharma Sentiment Index; BPSI; Endpoints News; biopharma sentiment survey; drug development sentiment; biotech investing sentiment; pharma industry outlook